MD-GASTROVIEW Drug Patent Profile
✉ Email this page to a colleague
When do Md-gastroview patents expire, and when can generic versions of Md-gastroview launch?
Md-gastroview is a drug marketed by Liebel-flarsheim and is included in one NDA.
The generic ingredient in MD-GASTROVIEW is diatrizoate meglumine; diatrizoate sodium. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Md-gastroview
A generic version of MD-GASTROVIEW was approved as diatrizoate meglumine; diatrizoate sodium by ADAPTIS on June 27th, 2022.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MD-GASTROVIEW?
- What are the global sales for MD-GASTROVIEW?
- What is Average Wholesale Price for MD-GASTROVIEW?
Summary for MD-GASTROVIEW
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Clinical Trials: | 3 |
| Patent Applications: | 397 |
| Drug Prices: | Drug price information for MD-GASTROVIEW |
| DailyMed Link: | MD-GASTROVIEW at DailyMed |
Recent Clinical Trials for MD-GASTROVIEW
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Guthrie Clinic | N/A |
| GE Healthcare | N/A |
| Asan Medical Center | N/A |
Pharmacology for MD-GASTROVIEW
| Drug Class | Radiographic Contrast Agent |
| Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for MD-GASTROVIEW
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liebel-flarsheim | MD-GASTROVIEW | diatrizoate meglumine; diatrizoate sodium | SOLUTION;ORAL, RECTAL | 087388-001 | Approved Prior to Jan 1, 1982 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
